Related Experiment Video
Updated: Jul 27, 2026
11:08
Dissection and Culture of Chick Statoacoustic Ganglion and Spinal Cord Explants in Collagen Gels for Neurite Outgrowth Assays
Published on: December 20, 2011
[Bone morphogenetic proteins and cholinergic neurons in the central nervous system]
I López-Coviella1, J K Blusztajn
1Department of Psychiatry; Boston University School of Medicine, Boston, MA, 02118, USA. coviella@bu.edu
Revista De Neurologia
|January 11, 2002
Summary
Bone morphogenetic proteins (BMPs) may induce cholinergic neuron development and maintain their neurotransmitter specificity in the central nervous system, offering potential brain disorder treatments.
Area of Science:
- Neuroscience
- Developmental Biology
- Molecular Biology
Context:
- Understanding neurotransmitter phenotype regulation is crucial for neurodegenerative disease research.
- Cholinergic neurons' development and maintenance mechanisms remain incompletely understood.
- Bone morphogenetic proteins (BMPs) are implicated in nervous system development.
Purpose:
- To investigate the role of BMPs in determining and maintaining the cholinergic neuronal phenotype.
- To explore the potential of BMPs in regulating neurotransmitter specificity.
Summary:
- BMPs may differentiate neuronal precursor cells into cholinergic neurons.
- BMPs appear to upregulate the cholinergic phenotype in existing neurons within the central nervous system.
- Evidence suggests BMPs play a significant role in cholinergic neuronal development and phenotype maintenance.
Impact:
- BMPs could be a therapeutic target for brain disorders characterized by cholinergic neuron dysfunction.
- This research may lead to novel strategies for neuroprotection and neuronal regeneration.
- Findings contribute to the fundamental understanding of neuronal differentiation and neurotransmitter specification.
Related Concept Videos
01:30Classification of Neurotransmitters
Neurotransmitters play a crucial role in the communication between neurons in the autonomic nervous system. Neurons in the autonomic nervous system can be cholinergic or adrenergic depending on the neurotransmitters synthesized. Cholinergic neurons use acetylcholine as their primary neurotransmitter. This includes all the preganglionic fibers of the sympathetic and pre- and postganglionic fibers of the parasympathetic nervous systems. In addition, neurons of the somatic nervous system also use...
01:23Cholinergic Neurons: Neurotransmission
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
01:25Cholinergic Receptors: Muscarinic
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
01:15Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:30Parasympathetic Signaling
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...